波士顿科学 BSX 深 沪
交易中 10-06 10:20:01 美东时间
42.47
+0.040
+0.09%
华盛通- 最 高50.38
- 今 开42.47
- 成交量 104.86万股
- 最 低 41.9397
- 昨 收 42.43
- 总市值 6068.96万
- 52周最高 105.65
- 市盈率 静 61.82
- 换手率 73.38%
- 52周最低 41.9397
- 委 比 84.48%
- 总股本 0.01亿
- 历史最高 109.4994
- 量 比 0.96
- 振 幅 19.89%
- 历史最低 4.79
- 每 手 1
- 风险率 22.04%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Elutia Obtains $8M Payment from Boston Scientific; Co. Now Fully Funded into 2029
Elutia Inc. (NASDAQ:ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced it has received the full $8 million held in escrow in connection with the sale of
10-02 04:51
FDA Flags Boston Scientific Catheter Recall
Boston Scientific recalls Imager II Angiographic Catheters over tip detachment defect. Learn about patient risks & FDA safety updates.
09-29 01:42
Alpha Buying: 4 Falling Knives Insiders Are Buying
There are dozens of reasons corporate executives sell shares. They may need money to pay taxes, buy a house, settle a divorce, diversify their wealth, or fund a new boat they will use three times before deciding they
09-11 00:16
去年净利润归零！先瑞达医疗终止在美临床项目，背后是美国7月发布的一则文件
医疗器械研发九死一生，终止临床项目的事情时有发生，但公司要付出不小的业绩代价。 8月12日，先瑞达医疗（HK06669，股价6.515港元，市值24.42亿港元...
08-13 17:47
'Boston Scientific Gets $42 Million Stent Patent Verdict Reversed' - Bloomberg
https://news.bloomberglaw.com/health-law-and-business/boston-scientific-gets-42-million-stent-patent-verdict-reversed
07-28 00:17
2.5秒消融、体内放疗！进博百天倒计时，企业亮出微创医疗硬核黑科技
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ （来源：上观新闻） 一根纤细的导管穿过血管抵达心脏，一组电极进入...
07-24 19:12
'Selling Winners, Buying Losers': Tech Stocks Drop as Energy Jumps to Start H2
July brings a sharp rotation trade in markets as investors shift from top performers to beaten-down names.
07-10 03:45
Wolfe Research Downgrades Boston Scientific to Peer Perform
Wolfe Research analyst Mike Polark downgrades Boston Scientific (NYSE:BSX) from Outperform to Peer Perform.
05-29 20:22
Boston Scientific Advances Coronary Calcium Treatment With Positive Trial Results
Boston Scientific reported positive FRACTURE trial results for its SEISMIQ 4CE coronary IVL catheter in severe CAD patients.
05-20 00:01
Boston Scientific Announces $2B Accelerated Share Buyback Program
Boston Scientific Corporation (NYSE:BSX) today announced that it has entered into an accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank, National Association for $2 billion (the repurchase price) of
05-18 19:14
